Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-6.41%
NET PROFIT MARGIN AVG 15Y
-3.25%
NET PROFIT MARGIN AVG 20Y
-0.73%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Enveric Biosciences, Inc.
Market Cap
$6.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.61M
Net Profit Margin
-1084.23%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.64M
Net Profit Margin
-10978.48%
TTM Avg
-12422.83%
3Y Avg
-10763.38%
5Y Avg
-10131.90%
Market Cap
$6.54M
Net Profit Margin
-84.79%
TTM Avg
-89.20%
3Y Avg
-105.63%
5Y Avg
-91.66%
Market Cap
$6.78M
Net Profit Margin
-611.47%
TTM Avg
-627.26%
3Y Avg
-917.71%
5Y Avg
-6297.45%
Market Cap
$6.97M
Net Profit Margin
-6523.04%
TTM Avg
-4247.49%
3Y Avg
-2263.82%
5Y Avg
-1493.48%
Market Cap
$6.30M
Net Profit Margin
-534.27%
TTM Avg
-983.65%
3Y Avg
-1060.24%
5Y Avg
-924.37%
Market Cap
$7.08M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.61M | -1084.23% | 0.00% | 0.00% | 0.00% |
| Aclarion, Inc. (ACON)vs › | $6.64M | -10978.48% | -12422.83% | -10763.38% | -10131.90% |
| Biomerica, Inc. (BMRA)vs › | $6.54M | -84.79% | -89.20% | -105.63% | -91.66% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.78M | -611.47% | -627.26% | -917.71% | -6297.45% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.97M | -6523.04% | -4247.49% | -2263.82% | -1493.48% |
| Femasys Inc. (FEMY)vs › | $6.30M | -534.27% | -983.65% | -1060.24% | -924.37% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.01M | 0.00% | 0.00% | -19.45% | -19.45% |
| KALA BIO, Inc. (KALA)vs › | $7.05M | 0.00% | 0.00% | -287.91% | -676.70% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 9.66% |
| 2020-09-30 | -11.33% |
| 2020-06-30 | -19.06% |
| 2020-03-31 | -18.58% |
| 2019-12-31 | -27.90% |
| 2019-09-30 | 0.45% |
| 2019-06-30 | -11.41% |
| 2019-03-31 | -17.41% |
| 2018-12-31 | -192.21% |
| 2018-09-30 | 53.89% |
| 2018-06-30 | -11.38% |
| 2018-03-31 | -14.21% |
| 2017-12-31 | -8.78% |
| 2017-09-30 | -32.46% |
| 2017-06-30 | -26.73% |
| 2017-03-31 | -5.85% |
| 2016-12-31 | -19.75% |
| 2016-09-30 | -17.09% |
| 2016-06-30 | -18.09% |
| 2016-03-31 | -16.54% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | -5.59% |
| 2015-06-30 | 2.82% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 6.47% |
| 2007-09-30 | 1568.88% |
| 2007-06-30 | 41.50% |
| 2007-03-31 | 64.96% |
| 2006-12-31 | -76.52% |
| 2006-09-30 | -91.22% |
| 2006-06-30 | -67.83% |
| 2006-03-31 | -172.55% |
| 2005-12-31 | -115.54% |
| 2005-09-30 | 13.49% |
| 2005-06-30 | 13.42% |
| 2005-03-31 | 3.02% |
| 2004-12-31 | 34.37% |
| 2004-09-30 | -39.24% |
| 2004-06-30 | -52.48% |
| 2004-03-31 | -72.53% |
| 2003-12-31 | -29.61% |
| 2003-09-30 | -31.20% |
| 2003-06-30 | -84.68% |
| 2003-03-31 | -22.40% |
| 2002-12-31 | -3.70% |
| 2002-09-30 | 2.31% |
